Pacritinib With Aza for Upfront Myelodysplastic Syndrome

Clinical trial NCT07387354 · WITHDRAWN

Trial details

NCT number: NCT07387354
Sponsor: Thomas Jefferson University
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes MDS Myelodysplastic Syndrome, Unclassifiable Hematologic Diseases Bone Marrow Disease Myeloproliferative Neoplasm

Start date: 2026-09-01
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.